Penn Capital Management Company, LLC
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1158202
PHILADELPHIA, PA
Position in ARQT
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$7,848,542
New position
Shares Held
333,130
first reported quarter
Ownership
0.266%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Penn Capital Management Company, LLC holds $79,843,281 across 7 Biotechnology names. ARQT ranks #5 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
256,767 | $23,720,135 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
95,456 | $19,057,790 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
541,960 | $18,003,911 | |
| 4 | SLNO |
Soleno Therapeutics Inc
|
268,785 | $8,998,921 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
333,130 | $7,848,542 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,510 | $1,837,379 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
12,676 | $376,603 |
All Filings in ARQT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,848,542 | 333,130 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||